The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line.
Acta Pharm Sin B
; 5(6): 554-63, 2015 Nov.
Article
en En
| MEDLINE
| ID: mdl-26713270
ADM, adriamycin; CAM, chorioallantoic membrane; CCK-8, cell counting kit-8; DMSO, dimethylsulfoxide; EPCs, endothelial progenitor cells; FBS, fetal bovine serum; FCM, flow cytometry; HRP, horseradish peroxidase; IC50, 50% inhibitory concentration; MD, molecular dynamics; Molecular docking; NS, normal saline; NSCLC, non-small cell lung cancer; Non-small cell lung cancer; PI, propidium iodide; PKB/AKT, protein kinase B; RMSD, root-mean-square deviation; Tan IIA, tanshinone IIA; Tanshinone IIA; VEGF, vascular endothelial growth factor; VEGF/VEGFR signal pathway; mOS, median overall survival; tRR, tumor response rate; vdW, van der Waals force
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Acta Pharm Sin B
Año:
2015
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
Países Bajos